News Room
Adcock Ingram delivers healthy financial results
2024/08/22 10:57:50Johannesburg – The Adcock Ingram Group is pleased to report a 10% increase in headline earnings per share for the year ended 30 June 2024.
[READ MORE]
Adcock Ingram reports a resilient trading performance in a difficult market for the six-months ended 31 December 2023
2024/02/22 00:00:00Johannesburg – The Adcock Ingram Group today reported an increase in turnover of 1% for the six-month period to 31 December 2023. Turnover grew in the Consumer and Hospital divisions, but was flat in the Prescription and Over-The-Counter divisions. This trading performance was achieved in a constrained environment where consumers remain under pressure from high interest rates, exchange rate depreciation, high inflation and continued loadshedding, all of which result in lower disposable income.
[READ MORE]
Adcock Ingram delivers healthy financial results
2023/08/23 09:04:45Johannesburg – The Adcock Ingram Group is pleased to report a 12% increase in headline earnings per share for the year ended 30 June 2023, in a challenging economic environment, characterised by currency weakness and volatility, poor economic growth and increasing pressure on consumer disposable income.
[READ MORE]
Adcock Ingram reports a healthy financial and operational performance for the six-months ended 31 December 2022
2023/02/22 09:39:56Johannesburg – The Adcock Ingram Group today reported an increase in turnover of 8%, with trading profit growth of 15%, for the six-month period ended 31 December 2022, attributed to its diverse and affordable portfolio of products, well-executed sales and marketing strategies, and a continued focus on customer service.
[READ MORE]
The Adcock Ingram Group reports an exceptional set of results for the year ended 30 June 2022
2022/08/25 07:21:32Johannesburg – The Adcock Ingram Group delivered an exceptional operational and financial performance for the year ended 30 June 2022. The Group reported a 12% increase in turnover, driven by the increase in demand for over-the-counter (OTC), and consumer healthcare products, following the lower and subsequent lifting of the lock-down levels, required during the COVID-19 pandemic.
[READ MORE]
Adcock Ingram reports strong operational and financial performance for the six months to 31 December 2021
2022/02/23 07:27:12Johannesburg – Adcock Ingram today reported an increase in turnover of 16%, an exceptional increase of 25% in trading profit, and excellent cash generation for the first half of the financial year to 31 December 2021, driven mainly by improved demand for its over-the-counter (OTC) and consumer healthcare products.
[READ MORE]
Adcock Ingram reports resilient performance under COVID-19
2021/08/25 00:00:00Johannesburg – The Adcock Ingram Group delivered a healthy set of results in the year ended 30 June 2021, with turnover increasing by 6%, despite the effects of the COVID-19 pandemic.
[READ MORE]
The Adcock Ingram Group reports a resilient trading performance for the six-months ended 31 December 2020
2021/02/24 07:17:11Johannesburg – The Adcock Ingram Group today reported a 4% increase in turnover for the six-month period to 31 December 2020. The Group achieved these sales in challenging trading conditions brought about by COVID-19, in a depressed economy, and declines in demand for certain categories of medicine and products.
[READ MORE]
Adcock Ingram reports satisfying results
2020/08/26 07:11:23Johannesburg – The Adcock Ingram Group is pleased to report a 4% increase in turnover for the year ended 30 June 2020. The Group achieved these results despite the challenging conditions such as the general economic downturn, significant cost-push due to Rand weakness, global supply chain disruptions, and declines in demand for certain categories of medicine and products.
[READ MORE]
Adcock Ingram Critical Care completes precautionary COVID-19 testing of primary contact employees
2020/04/28 08:38:13Midrand – On Thursday, 23 April, an employee at the Aeroton facility tested positive for COVID-19, and as a precaution, 57 employees from a specific operating department were referred to a private pathology laboratory for testing on the same day, and were self-quarantined based on the primary contact trace in line with the company’s COVID-19 protocols.
[READ MORE]
Adcock Ingram employee has tested positive for COVID-19
2020/04/24 08:41:43Midrand – An employee in the Adcock Ingram Critical Care manufacturing facility has tested positive for COVID-19, and 50 other employees have undergone testing today, and self-quarantined based on the primary contact trace.
[READ MORE]
Adcock Ingram applauds its workforce, and the Executive Directors make a pledge to the Solidarity Fund
2020/04/15 10:26:08Midrand – As a leading pharmaceutical company in South Africa, Adcock Ingram salutes the President and his Cabinet on the swift and decisive action that has been implemented regarding the management of Covid-19 in order to contain the outbreak of the virus in an effort to prevent further loss of lives. The Company also applauds and give thanks to our public and private sector healthcare workers, emergency personnel, police and military personnel, and other persons who are delivering essential services to South Africa
[READ MORE]